VRTX stock verdict - Avoid
VRTX
Vertex Pharmaceuticals Incorpor
AVOIDHealthcare
$479.00
Overvalued (≥ exit)
$479.00
Heavy$153.47Buy$204.62Fair$255.78Exit$306.93
FUNDAMENTAL58
TECHNICAL—
TRUST SCORE
30Very Low
confidence in this read — data completeness, earnings quality & coverage
Technicals: insufficient price history
PROS
- Balance sheet holds net cash (cash exceeds total debt)
CONS
- Trades above the model's exit level ($306.93) — overvalued on this framework
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
SECTOR PEERS
Analysis as of 2026-07-28 · price live, fundamentals from latest filings
FAQ
Why is VRTX rated Avoid?
VRTX (Vertex Pharmaceuticals Incorpor) is rated Avoid because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Overvalued (≥ exit). Balance sheet holds net cash (cash exceeds total debt)
Is VRTX overvalued right now?
VRTX is trading at $479.00 versus an estimated fair value of $255.78. That puts the stock in avoid territory on this framework. Trades above the model's exit level ($306.93) — overvalued on this framework
What should I watch before acting on VRTX?
Watch the trust score of 30, the earnings-quality checks, and any red flags. Trades above the model's exit level ($306.93) — overvalued on this framework